Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Regenerative Medicine is Scopus-indexed (Q2, CiteScore 3.9), WoS SCIE. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 1746-0751Verify ISSN ↗1746-076XVerify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Embryology | 9 / 25 | 66th | Q2 |
| Biomedical Engineering | 189 / 342 | 44th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2006–present, best quartile Q2, CiteScore 3.9.
Regenerative Medicine is Q2 in Embryology (rank 9 of 25) and Q3 in Biomedical Engineering (rank 189 of 342), by CiteScore 2025.
Regenerative Medicine is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.9, which places it in quartile Q2 at the 66th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.487, quartile Q2, with an H-index of 80.
Regenerative Medicine is published by Taylor and Francis Ltd. Its print ISSN is 1746-0751 and its online ISSN is 1746-076X.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Regenerative Medicine has an h-index of 88 and a 2-year mean of 1.91 citations per paper (OpenAlex). Its Scopus CiteScore is 3.9, quartile Q2. On 2-year citations it ranks #8 of 25 Scopus journals in Embryology.
Regenerative Medicine published 64 papers in 2025; its busiest recent year was 2022 with 111. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2024–2026), authors are most often from United States (20.8%), United Kingdom (12%) and Iran (9.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 6 retracted papers are recorded (2.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.